Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Mereo is a new UK-based speciality biopharmaceutical company.
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 16 different industry categories.
Among tracked funding rounds, ElevateBio received $401.0M in a Series D round. Samsara BioCapital's total known invested capital is $14.2B.
Samsara BioCapital's average investment size is $107.7M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Pathalys Pharma, Abata Therapeutics, Autobahn Therapeutics, LENZ Therapeutics, Mereo Biopharma. These companies were founded in 2020 or later.